HomePress ReleaseEIN PresswireIntegral BioSystems Attending Drug Development Contracting & Outsourcing Conference Sept 21, 2023...

Integral BioSystems Attending Drug Development Contracting & Outsourcing Conference Sept 21, 2023 in New Brunswick, NJ

Integral BioSystems can be exhibiting at Desk #27 on Sept 21, 2023 on the Hyatt Regency Resort in New Brunswick, NJ

Regardless of the precise nature of your lively ingredient, we will help you formulate it to be most protected and efficient in the ultimate drug product”

— Dr. Shikha Barman

BEDFORD, MASSACHUSETTS, USA, August 14, 2023/ — Positioned in a ten,000 sq. foot facility in Bedford, MA, Integral BioSystems’ scientists are specialists in formulation and analytical technique growth, stability assessments, bioanalytics, and scale-up/know-how switch.

Our scientists are extensively expertise with Biodegradable Microspheres/ Nanospheres, Drug Suspensions, Generics, 505B1, OTC and 505B2 Merchandise, Small Molecules, Proteins (Biosimilars) and Nucleic acid formulations (DNA, RNAi), Vaccines. Supply routes obtainable are : Injectables, Ophthalmics, Intranasals, Otic, Pulmonary, Dermal. Our growth capabilities embody R&D and cGLP; R&D and cGLP stability research, toxicology provides, course of growth, scale-up, and know-how switch.

With over 28 years of expertise in all phases of cell and tissue focused, sustained launch pharmaceutical formulation growth, the agency’s CEO and President, Dr. Shikha P. Barman, can be readily available to debate the particular necessities of attendees.

About Integral BioSystems

Integral BioSystems is a specialty drug supply contract analysis group that provides an built-in, sensible method to formulation growth tasks for each small molecule and huge molecule drug candidates. Providing contract providers to pharmaceutical firms to develop drug merchandise via its CMC choices in analytical technique growth, formulation growth, course of growth, scale-up and know-how switch, the corporate additionally companions with pharmaceutical firms to co-develop merchandise based mostly on its proprietary pharmaceutical supply methods.

The Firm has developed quite a few dosage varieties for ophthalmic functions. Integral BioSystems has a translational method to drug growth, customizing supply methods to realize the biologically efficient targets of the remedy. Dosage varieties are personalized to realize sustained launch or focused, tissue-focused supply or fast-release/immediate supply, relying upon the specified product attributes.

For these looking for to develop a formulation for a brand new drug substance, a 505b2 product or a generic drug product, Dr. Barman can be obtainable to reply questions on attainable methods in your explicit software.

Dave Karasic
Integral BioSystems, LLC
+1 617-820-8483
e mail us right here


Most Popular